NK CellTech Announces FDA Clearance for Clinical Trial of NK010
- Written by PR Newswire
SHANGHAI, Jan. 22, 2024 /PRNewswire/ -- On January 17, 2024, NK CellTech Co., Ltd. (NK CellTech), a leading biotech company focused on the development of NK cellular therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of NK010, the non-genetically modified natural killer cells. NK010 is the first...
Read more: NK CellTech Announces FDA Clearance for Clinical Trial of NK010














